Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Novel Therapeutic Approaches for Treatment of Covid-19 Publisher Pubmed



Hosseinkhannazer N1, 2 ; Shokoohian B3, 4 ; Shpichka A5, 6 ; Aghdaei HA7 ; Timashev P5, 6, 8, 9 ; Vosough M3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
  4. 4. Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Institute for Regenerative Medicine, Sechenov University, Moscow, Russian Federation
  6. 6. Chemistry Department, Lomonosov Moscow State University, Moscow, Russian Federation
  7. 7. Department of Molecular Biology, Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  8. 8. Department of Polymers and Composites, NN Semenov Institute of Chemical Physics, Moscow, Russian Federation
  9. 9. Institute of Photon Technologies, Federal Research Center Crystallography and Photonics RAS, Moscow, Russian Federation

Source: Journal of Molecular Medicine Published:2020


Abstract

To date, there is no licensed treatment or approved vaccine to combat the coronavirus disease of 2019 (COVID-19), and the number of new cases and mortality multiplies every day. Therefore, it is essential to develop an effective treatment strategy to control the virus spread and prevent the disease. Here, we summarized the therapeutic approaches that are used to treat this infection. Although it seems that antiviral drugs are effective in improving clinical manifestation, there is no definite treatment protocol. Lymphocytopenia, excessive inflammation, and cytokine storm followed by acute respiratory distress syndrome are still unsolved issues causing the severity of this disease. Therefore, immune response modulation and inflammation management can be considered as an essential step. There is no doubt that more studies are required to clarify immunopathogenesis and immune response; however, new therapeutic approaches including mesenchymal stromal cell and immune cell therapy showed inspiring results. © 2020, Springer-Verlag GmbH Germany, part of Springer Nature.
Other Related Docs
13. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)
15. Covid-19: Significance of Antibodies, Human Antibodies (2020)
17. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)
19. Immunotherapy for Sars-Cov-2: Potential Opportunities, Expert Opinion on Biological Therapy (2020)
27. The Immunologic Basis of Covid-19: A Clinical Approach, Journal of Cellular and Molecular Anesthesia (2020)
39. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)
40. Dynamic Changes of Lymphocyte Subsets in the Course of Covid-19, International Archives of Allergy and Immunology (2021)
47. The Role of Type I Interferon in the Treatment of Covid-19, Journal of Medical Virology (2022)